Paradigm, Bristol Myers Squibb partner for clinical trial operational model
Bristol Myers will be able to enrol patients through providers across Paradigm Network of health systems.
09 October 2023
09 October 2023
Bristol Myers will be able to enrol patients through providers across Paradigm Network of health systems.
Avidity's lead candidate AOC 1001 works by leveraging its antibody oligonucleotide conjugate platform to target the root cause of DM1.
Merck’s bladder cancer therapy, Keytruda, has met one of two endpoints as part of its Phase III AMBASSADOR trial, helping to stave off disease-free survival for patients.
The researchers revealed insights on the complex mechanisms underlying antibody-based therapies for the patients.
The SiPore21 acts like a sieve, physically preventing enzymes from interacting with food and reducing its breakdown into its basic units.
Serum is already India's most valuable unlisted company and it is looking to expand into wealthier nations.
The dosing was administered without any safety issues.
Change from baseline in BCVA letters in the study eye, based on an average at week 44, 48 and 52, is the primary endpoint.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.